Long-term management of elderly patients with rheumatoid arthritis treated with tocilizumab: comparison of patients over and under 75 years old
This large French nationwide study conducted in patients who initiated TCZ for RA provide reassuring results for patients aged at least 75 years compared to younger patients, in particular regarding treatment maintenance. No new safety signals were identified in elderly patients.
Authors
- Bernard Combe
- Bruno Fautrel (ORCID: https://orcid.org/0000-0001-8845-4274)
- Isabelle Idier
- Alain Saraux
Institutions
- Inserm (FR)
- Université de Bretagne Occidentale (FR)
- Université de Montpellier (FR)
- Sorbonne Université (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Pitié-Salpêtrière Hospital (FR)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-09-05
- DOI
- https://doi.org/10.3389/fmed.2025.1538170
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Chugai Pharmaceutical